ALIF + TDR vs. 2-level circumferential fusion + TLIF for lumbar degenerative disc disease .
This study has been identified as potentially high impact.
OE's AI-driven High Impact metric estimates the influence a paper is likely to have by integrating signals from both the journal in which it is published and the scientific content of the article itself.
Developed using state-of-the-art natural language processing, the OE High Impact model more accurately predicts a study's future citation performance than journal impact factor alone.
This enables earlier recognition of clinically meaningful research and helps readers focus on articles most likely to shape future practice.
OrthoEvidence Journal (OE Journal) - ACE Report
OE Journal. 2016;4(24):33 Eur Spine J. 2016 May;25(5):1558-66.62 patients with bi-segmental degenerative disc disease at L4-S1 were randomized to receive either hybrid anterior lumbar interbody fusion (ALIF) at L5/S1 with total disc replacement (TDR) at L4/5 or conventional 2-level circumferential fusion with transforaminal lumbar interbody fusion (TLIF) for the purpose of comparing pain and radiographic parameters throughout a 37-month follow-up period. Results demonstrated that patients in the Hybrid group had significantly reduced pain scores when compared to the Fusion group at both the 1-week and 37-month follow-up points. Additionally, significant increases in segmental lordosis were mainly observed at L4-S1 in the hybrid group (instrumented levels only) compared to L1/-S1 in the Fusion group (instrumented and uninstrumented levels).
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
Are you affiliated with one of our partner associations?
Click here to gain complimentary access as part your association member benefits!
0 of 4 monthly FREE articles unlocked
